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Aqueductal CSF stroke volume 
measurements may drive 
management of shunted idiopathic 
normal pressure hydrocephalus 
patients
Antonio Scollato1, Saverio Caini2, Lucia Angelini3, Giancarlo Lastrucci3,4, Nicola Di Lorenzo5, 
Berardino Porfirio6,7* & Pasquale Gallina3,4,6 
CSF shunting with adjustable valve is the treatment of idiopathic normal pressure hydrocephalus. The 
opening pressure valve setting is left to the neurosurgeon’s experience. Aqueductal CSF stroke volume 
by phase-contrast magnetic resonance measures the CSF passing through the Sylvian aqueduct 
and it changes with intracranial hydrodynamics. We sought to identify a window of stroke volume 
differences associated with the best clinical outcome and lowest rate of complications. The records 
of 69 patients were reviewed. At every clinical check, stroke volume, opening pressure valve, clinical 
outcome, and CSF overdrainage were analyzed. The correlation between stroke volume differences 
and negative outcome was also analyzed. The median follow-up was 2.3 years (range 0.3–10.4 years). 
The odds of negative outcome between two consecutive checks significantly increased by 16% (95%CI 
4–28%, p = 0.006). Taking the lowest risk group as reference, the odds ratio of negative outcome was 
1.16 (95%CI 0.51–2.63, p = 0.726) for SV differences less than − 37.6 µL, while it was 1.96 (95%CI 0.97–
3.98, p = 0.062) for stroke volume changes above + 23.1 µL. Maintaining stroke volume values within a 
definite range might help maximize clinical benefit and avoid the risk of CSF overdrainage.
Idiopathic normal pressure hydrocephalus (iNPH) is a derangement of intracranial hydrodynamic leading to 
CSF endo-ventricular  accumulation1,2. With the boost of arterial pulsation, the brain is compressed against the 
calvaria, with progressive vascular damage, atrophy, and reduction of ventricular squeezing, which is the force 
moving  CSF3. Aqueductal CSF stroke volume (SV) by phase-contrast magnetic resonance measures the volume of 
the CSF passing through the Sylvian aqueduct under a heart  cycle4. SV is indicative of brain  pulsatility4. SV meas-
urement has been proposed in the management of iNPH, as a predictor of CSF shunting  outcome5–7, although 
 controversially8–10. In un-shunted patients, after an increase at the onset of the disease, SV reaches a plateau, 
then a decline in association with a worsening of the clinical picture, as cerebrovascular damage  progresses11. 
In patients receiving ventriculoperitoneal shunt placement with a fixed valve, SV decreases after  surgery12. Sub-
sequently, there is further decrement related to the brain atrophy, which parallels loss of  benefit12. A relevant 
decrease of SV values heralded intracranial fluid collection (IFC), a CSF overdrainage-related complication, 
which can be corrected by valve closure although at the expense of the clinical  benefits12.
Adjustable valve allows for non-invasive matching of the opening pressure valve (OPV) with the patient’s 
intracranial hydrodynamics and clinical course, leading to gains in terms of outcome and treatment of overdrain-
age  complications13. However, due to the lack of tools to predict post-shunting deterioration/complications, the 
physician can only keep track of events and correct them by valve adjustment. Nevertheless, the OPV setting is 
empirical, which results on the one hand in the risk of an insufficient CSF drainage to obtain a benefit, on the 
other one in the risk of overdrainage.
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Here, we aimed at identifying a range of SV changes achievable by means of OPV resettings during follow-up 
that might help maximize a patient’s clinical benefit while avoiding overdrainage complications.
Methods
This study was performed according to the Declaration of Helsinki principles. We reviewed (January–March 
2019) the SV changes in relationship with clinical course of a population of iNPH patients who have undergone 
ventriculoperitoneal shunt placement with adjustable valve (ProGav, Aesculap, Inc or Codman Hakim, Johnson 
and Johnson). This was a retrospective observational study of already existing data, without any further interven-
tion and a formal institutional review board approval was not mandatory. Data were anonymized before carrying 
out the analyses. Patients provided consent to use their clinical data for research purposes. iNPH management 
protocols were  reported14. Informed consent to clinical procedures was obtained from all patients. iNPH had 
been diagnosed based on at least two disturbances of the Hakim’s-triad15, and Evans ratio > 0.30. Cognitive func-
tions, including orientation, registration, attention, calculation, recall, and language, were evaluated by using the 
Mini-Mental State Examination (MMSE)16 in which the minimum score is zero and the maximum is 30. A score 
of 23 is indicative of cognitive impairment. Urinary disorders were evaluated by a urinary incontinence scale 
graded in 4 categories: normal urinary function (grade 0), urgent urination or sporadic incontinence (grade 1), 
frequent incontinence (grade 2), and complete incontinence (grade 3)12. Gait disorders were evaluated by a gait 
scale graded into 4 categories: normal gait (grade 0); discrete imbalance when turning with short steps, widened 
base, and occasional falling (grade 1); frequent falls and aid needed for ambulation (grade 2); and impossible gait 
(grade 3)12. Patients were selected for ventriculoperitoneal shunt placement on the basis of improvement after 
lumbar  drainage14. A gain by ≥ 2 points combining the urinary and gait scales, or a gain by one point in urinary 
or gait scales and by ≥ 3 points on the MMSE was considered an improvement.
Inclusion criteria for the present study were at least two SV measurements, absence of other neurological 
diseases and of perioperative complications. Patients who received other CSF shunting diagnostic/therapeutic 
procedures were excluded.
Patients’ sex, age at ventriculoperitoneal shunt placement, MMSE, gait and urinary scales scores obtained 
at any check (i.e. clinical status evaluation, possibly associated with SV measurement and/or OPV resetting) 
were noted. Patients were categorized as unimproved or improved according to the same criteria used to assess 
outcome of lumbar drainage. Patients whose clinical status did not change were categorized as worsened. We 
calculated the time interval and the difference in SV (∆SV) and OPV (∆P) values between each pair of subsequent 
checks. The occurrence of headache, IFC and shunt malfunctioning were also recorded.
Descriptive analyses were conducted using median and range (for continuous variables) and contingency 
tables (for categorical variables), whereas differences in distribution were tested using the Wilcoxon rank-sum 
test and the chi-square test. Missing data were imputed through a multiple imputation by chained equations 
procedure, using truncated linear regression for continuous variables and logistic regression for binary vari-
ables. For each patient, we separately considered the first post-shunt SV measurement, to relate the patients’ 
clinical benefit to the achieved ∆SV, and all subsequent measurements, to identify the ∆SV associated with the 
best outcome, while minimizing the risk of overdrainage. We used generalized estimating equations to study the 
relationship between ∆SV (independent variable) and the outcome (dependent variable), adjusting for relevant 
covariates (checks in which a shunt malfunctioning was detected were not used)17. Alternative models were fitted 
in which ∆SV was entered either as absolute or percentage value, and in which the dependent variable was the 
clinical status, the presence of overdrainage complications (IFC and/or headache). ∆SV was initially modelled 
in quintiles and deciles; afterwards, deciles of ∆SV were empirically merged into broader groups to maximize 
contrasts and identify, in a data-driven way, the range of ∆SV associated with the highest likelihood of positive 
outcome. Covariates adjusted for in the models were the patient’s sex, age, and baseline MMSE, the baseline SV 
value and that measured at the previous check, and the number of checks that had taken place until that point. 
The statistical analyses were conducted using Stata Software Release 14. Tests were two-tailed and considered 
as significant when p-value < 0.05.
Results
Sixty-nine patients (48 males) met the selection criteria. Four-hundred-sixty-two checks were performed with 
355 SV measurements. Median patients age was 76 years (range 67–86 years); median baseline MMSE value was 
23 (range 12–28); median follow-up was 2.3 years (range 0.3–10.4 years). Demographic and clinical details of 
the patients are in Supplementary Information (SI) 1.
Baseline and follow-up SV and OPV data. OPV value at surgery was 110  mmH2O in 56 patients 
(81.2%), 120  mmH2O in 12 (17.4%), 130  mmH2O in one (1.4%). Sixty patients (SI 1) underwent baseline SV 
measurement (median 100.5 µL, range 35–300 µL). The median ∆SV was − 9 µL (range − 123, + 85 µL) between 
the first check and the baseline, and − 16 µL (range – 150, + 109 µL) between the last check and the baseline.
Eight patients did not undergo OPV resetting. In the remaining 61 patients, the median number of resettings 
was two (range 1–11), with the median ∆P between the last OPV resetting and the OPV setting at surgery equal 
to − 10  mmH2O (range − 40, + 80  mmH2O). The median interval time between two consecutive OPV resettings 
was 0.89 years (range 0.3–8.7). See Table 1. 
Baseline and follow-up SV and OPV data in the patients who experienced overdrainage-related 
complications and comparisons with non-complicated ones. Twenty-five patients experienced 
complications, of whom 14 had only headache, nine had only IFC, and two had both headache and IFC.
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Among the eleven patients who experienced IFC, OPV value at the occurrence of IFC ranged between 110 
and 40  mmH2O. The median interval time from surgery to IFC was 1.9 years (range: 0.2–6.2). After IFC, OPV 
was increased by 30 to 70  mmH2O. Patients who experienced IFC had more checks than those who did not 
(median 9 vs. five, p = 0.003), while there were no differences in terms of age, gender and MMSE. The median 
∆SV was − 33 µL when IFC occurred, and − 4 µL when it did not (p < 0.001) (Table 2).
Among the sixteen patients who experienced headache, OPV value at the occurrence ranged between 160 
and 30  mmH2O. Headache occurred at a median of 0.4 years after surgery (range 0.2–9 years), and resolved in 
all patients upon increasing the OPV value by 10 to 50  mmH2O. Patients characteristics (gender, age, MMSE, 
number of checks and resettings) did not differ between patients who experienced headache compared to those 
who did not.
SV changes in patients who experienced valve malfunctioning. Fourteen patients experienced 
shunt malfunctioning; the shunt system was replaced in all. Seven patients received SV measurement at the 
check when the malfunction was recognized. In two of these, the malfunction was heralded by an increase of SV 
(from 94 to 135 µL, and from 144 to 189 µL); in two others, SV remained stable despite OPV resettings. In three 
cases, SV presented marginal changes.
Risk of worsening of Hakim’s-triad and of overdrainage complications related to ∆SV. The 
risk of worsening of Hakim’s-triad had a rising trend as quintiles progressed. Particularly, the OR of a worsen-
ing of Hakim’s-triad was increased by over 80% for ∆SV above + 13.1 µL see SI 2. The contrast was maximized 
(and achieved statistical significance) by comparing deciles 7–10 versus 1–6 of the distribution of ∆SV: the OR 
Table 1.  Imaging and opening pressure valve data at baseline and during follow-up in 69 idiopathic normal 
pressure hydrocephalus patients who underwent ventriculoperitoneal shunt placement with adjustable valve. 
n. number; OPV opening pressure valve; pt(s) patient(s); SV aqueductal cerebrospinal fluid stroke volume; 
VPSp ventriculoperitoneal shunt placement. Clinical check indicates the clinical evaluation, possibly associated 
with SV measurement and/or OPV resetting; ∆SV indicates the difference between SV values at baseline and 
during follow-up; ∆P indicates the difference of OPV setting at surgery and during follow-up.
n. of clinical checks 462
n. of SV measurements 355
Median Range
SV baseline in µL 100.5 35–300
∆SV at first post-surgical check in µL − 9 (− 13.7%) − 123, + 85 (− 84.1%, + 138%)
∆SV at last check in µL − 16 (− 29.7%) − 150, + 109 (− 85%, + 107%)
OPV value at VPSp in  mmH2O 110 in 56 pts 120 in 12 pts 130 in 1 pt
∆P at last check in  mmH2O − 10 − 40, − 80
n. OPV resettings/pt 2 1–11
Table 2.  Aqueductal cerebrospinal fluid stroke volume changes, opening pressure valve data during follow-up, 
in 11 cerebrospinal fluid shunted patients with idiopathic normal pressure hydrocephalus who experienced 
intracranial fluid collection and comparison with no complicated patients. CI confidence interval, ∆T time 
interval, IFC intracranial fluid collection, n. number, OPV opening pressure valve, pt(s) patient(s), VPSp 
ventriculo-peritoneal shunt placement. Clinical check indicates the clinical evaluation possibly associated with 
aqueductal cerebrospinal fluid stroke volume (SV) measurement and/or OPV resetting; in IFC patients ∆SV 
indicates the difference between SV values from the check where IFC was detected and the previous one, while 
in patients who did not experience IFC indicates the median of SV changes during follow-up.
n. events/pt 2 in 1pt, 1 in 10 pts
OPV value in mmH2O 
at IFC 110 in 2 pts, 90 in 1 pt, 70 in 1 pt, 60 in 3 pts, 40 in 2 pts
Median Range
∆T from VPS to IFC (years) 1.9 0.2–6.2
pts who experienced IFC pts who did not experience IFC
p valueMedian Range Median Range
n. checks/pt 9 (1–17) 5 (1–10) 0.003
% of clinical checks where 
OPV resetting were per-
formed
54.5% (95%CI 44.2–64.4) 45.2% (95%CI 39.4–51.1) 0.109
∆SV in µL
− 33 − 80, + 1 − 4 − 135, + 108
 < 0.001
(− 25.4%) (− 45.7%, + 1.2%) (− 3.8%) (− 88%, + 560%)
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for the comparison of the former vs. the latter was 1.86 (95%CI 1.03–3.38, p = 0.041). The risk of worsening of 
Hakim’s-triad increased significantly at each subsequent check (OR 1.15, 95%CI 1.05–1.28, p 0.005), see SI 3. No 
associations were found with patients’ age, sex, and baseline MMSE or SV.
The results of the same analysis conducted using the occurrence of overdrainage complications as outcome 
were shown in SI 4. The lowest risk of overdrainage was observed for the deciles from the fourth to the ninth 
(corresponding to the range from − 22.4 to + 61.0 µL) in the distribution of ∆SV. Taking this category as a refer-
ence, the OR was 2.23 (95%CI 0.85–5.83, p = 0.101) for the lowest deciles (from first to third, range from − 246.9 
to − 22.4 µL), and 2.34 (95%CI 0.40–13.84, p 0.348) for the top decile of the distribution (from + 61.0 to + 253.8 
µL) (SI 5). The OR for females was 2.53 (95%CI 0.78–8.21, p 0.123); no association with the others parameters 
was found.
We finally considered as the outcome the risk of having either a worsening of Hakim’s-triad or an overdrain-
age complication (results in SI 6). The risk was lowest for the deciles in the ∆SV distribution from the third to 
the seventh (corresponding to ∆SV ranging between − 37.6 and + 23.0 µL). Taking this as a reference, the OR 
for this composite outcome was 1.16 (95%CI 0.51–2.63, p 0.726) for the two lower deciles (∆SV from − 246.9 
to − 37.6 µL), and 1.96 (95%CI 0.97–3.98, p 0.062) in the upper three deciles (from + 23.1 to + 253.8 µL) (SI 7 
and Fig. 1). The OR increased between each pair of consecutive checks (1.16, 95%CI 1.04–1.28, p 0.006) and was 
higher (close to statistical significance) among females (1.80, 95%CI 0.93–3.48, p 0.079); no other parameter was 
associated with significant results.
Discussion
SV decreased of a median 13.7% after shunting due to the opening of an alternative way for the CSF flow asso-
ciated with clinical benefit in most of patients (94%). The possibility of changing the OPV makes it possible 
to counteract the loss of benefit with the progression of the disease, at the expense of the risk of overdrainage. 
However, SV continues to decrease due to the course of degeneration phenomena and the reduction of cerebral 
pulsatility which will lead to a “point of no return”, i.e. the moment when the correlation between the amount of 
drained CSF, SV trend and clinical outcome will be lost. The risk of worsening of Hakim’s-triad and occurrence 
of overdrainage increased significantly by 16% between one check and the following one. Since the “point of 
no return” is unknown (due to the limited number of patients with adequately long follow-up), we sought to 
identify a window of ∆SV values that maximized clinical benefits and minimized the risk of overdrainage. To 
do so, we ordered all checks, irrespective of the patients, according to ∆SV values and taking into account the 
longitudinal nature of the data (with patients contributing a varying number of measurements over time to the 
study database).
Overdrainage complications were heralded by ∆SV lower than − 22.4 µL (OR 2.23, p 0.101) without cor-
relation with time after shunting and, therefore, with the progression of brain degeneration. While statistical 
significance was not achieved (possible because of the limited sample size), the strength of the association and the 
solid scientific rationale suggest that the observed association might be real. These complications are iatrogenic, 
most likely consequent by the lack of clear guidance of the values at which the valve has to be reset. A risk of 
overdrainage complications was found also for ∆SV upper than + 61.0 µL (OR 2.34). While a chance finding may 
not be excluded (the p-value for this association was 0.348), this paradoxical result might be the consequence of 
our having grouped together IFC and headache, which may indeed be caused by overdrainage but also have other 
causes. Particularly, headache was self-reported and not investigated specifically, which may have led to some 
Figure 1.  Histogram of the risk of clinical worsening and occurrence of cerebrospinal fluid overdrainage 
complications as deciles of difference in aqueductal cerebrospinal fluid stroke volume (∆SV). ∆SV indicates the 
difference between aqueductal cerebrospinal fluid stroke volume values at any clinical check and the previous 
one. ∆SV deciles corresponding to maximum risk are shown in black.
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misclassification. These considerations are strengthened by the finding of a non-significantly, but substantially 
higher risk of overdrainage complications among females (OR 2.53, p 0.123), who suffer from headaches more 
than  males18. Further investigations taking advantage of an accurate definition of overdrainage-related headache 
might lead to a larger ∆SV window i.e. more room to pursue clinical benefit.
The association between better patient’s outcome and greater baseline SV values is  known7,12. However, since 
outcome can be improved until the “point of no-return” is reached, SV baseline value should not be used as a 
criterion to exclude patients from shunting. Prospective studies might stratify patient’s baseline SV value associ-
ated with duration and intensity of clinical improvement. In patients with relatively low baseline SV values, the 
balance between surgical  risks19 and the entity of benefit will drive the decision. Baseline SV value could be used 
to choose OPV setting at surgery. In clinical practice, the surgical valve setting is standard, mostly at 110 or 120 
 mmH2O13. In patients with severe cerebral atrophy, this setting may not be sufficient to make the valve work 
efficiently. In patients with a fixed valve, this results in a negative outcome from the beginning; in patients with 
adjustable valve, instead, the possibility to find the best post-shunt OPV setting exists, but to date, this optimal 
value is searched only through reiterated empirical OPV resettings.
Extreme rises of SV values forewarn shunt  malfunctioning12. Here, the rise of SV values may just lead to 
suspect malfunctioning. A tendency for SV to remain stable while neurological status does not improve despite 
OPV downward resetting should also lead to a suspicion of shunt malfunctioning.
This study presents limitations. The checks were not performed at regular intervals and their frequency was 
sometimes determined based on the patients’ clinical condition. SV was not systematically measured, and the 
outcome was not assessed, at every check. This imposed the need for a multiple imputation to be carried out to 
enhance the reliability of the results. Overall, limitations did not affect the methodological robustness of analytical 
procedures that were adopted. Particularly, our methodology took into account the potential misclassification 
of patients’ outcome mentioned above and the study size possibly not sufficient to detect clinically relevant, yet 
moderate changes (e.g. by less than 50%) in the frequency of negative outcome. Therefore, our study showed 
clearly discernible and biologically plausible associations and trends between ∆SV values and outcome. While 
the trend in the association between ∆SV values and patient’s symptoms seems convincing, the optimal cut-offs 
we identified may be specific of our population.
Conclusions
Upon confirmation from future studies with a larger population size and more accurate definition of outcomes 
(which would lead to greater statistical power and thus clearer results), the ∆SV window may permit, by either 
up or down OPV regulation leading to small ∆SV, to optimize the clinical course of shunted patients and extend 
the spectrum of patients who may benefit from shunting. The availability of an accurate prognostic  test7,14, to 
exclude from surgery non-hydrocephalic patients, and a range of ∆SV values within which the clinical outcome 
is maximized, may provide relief to patients regardless of their degree of brain atrophy. Stratification of patients 
according to their intracranial hydrodynamics, hence with different optimal ∆SV windows, might allow a bet-
ter outcome within each subgroup. Occurrence of post-shunting  hypoacusis20 and  glaucoma21, should also be 
taken into account when determining the optimal ∆SV window. Once the correlation between OPV values and 
the correspondent ∆SV is understood, it would be worth design adjustable valves having a greater capacity for 
fine-tuning.
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